Chang David J.
Chief Medical Officer
- Shares
- 8,800
- Price
- $2.26
- Value
- $19,888
CABA
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 1 CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$296,189
8 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
8
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
1 executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CABA overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
This option shall vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Corporation's stockholders.
Voluntary purchases and sales; administrative noise stays hidden.
Chang David J.
Chief Medical Officer
Binder Gwendolyn
President, Science & Tech.
Tomasello Shawn
Director
Gavel Steve
Chief Commercial Officer
Bollard Catherine
Director
Nichtberger Steven
President & CEO
Simon Mark
Director
Gerard Michael
General Counsel
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | Chang David J. Chief Medical Officer | Purchase | 8,800 | $2.26 | $19,888 | |
| Jan 21, 2026 | Binder Gwendolyn President, Science & Tech. | Purchase | 11,312 | $2.19 | $24,763 | |
| Jan 21, 2026 | Tomasello Shawn Director | Purchase | 22,725 | $2.21 | $50,322 | |
| Jan 21, 2026 | Gavel Steve Chief Commercial Officer | Purchase | 22,170 | $2.27 | $50,215 | |
| Jan 21, 2026 | Bollard Catherine Director | Purchase | 4,405 | $2.27 | $9,982 | |
| Jan 21, 2026 | Nichtberger Steven President & CEO | Purchase | 45,000 | $2.24 | $100,778 | |
| Jan 21, 2026 | Simon Mark Director | Purchase | 11,061 | $2.28 | $25,261 | |
| Jan 21, 2026 | Gerard Michael General Counsel | Purchase | 6,600 | $2.27 | $14,979 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.